PETA GAY BEZEK: Open Payments
NPI 1396281911 · NAPA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,467 in 11 payments from 7 companies in 2025. Trend: 2023 $67 · 2024 $161 · 2025 $1,467
Consulting: $1,110Food & beverage: $357
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $1,127 |
| Axsome Therapeutics, Inc. | 2 | $120 |
| Teva Pharmaceuticals USA, Inc. | 1 | $115 |
| Vanda Pharmaceuticals Inc. | 1 | $34 |
| ABBVIE INC. | 2 | $33 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| Lundbeck LLC | 1 | $17 |
Products named: Auvelity, AUSTEDO XR, HETLIOZ, VRAYLAR, INVEGA SUSTENNA, COBENFY, REXULTI.
Industry payments across CA — which companies pay providers there.
